Literature DB >> 17011168

Irradiation exacerbates cortical cytopathology in the Eker rat model of tuberous sclerosis complex, but does not induce hyperexcitability.

Naranzogt Tschuluun1, H Jürgen Wenzel, Philip A Schwartzkroin.   

Abstract

Tuberous sclerosis complex (TSC) is an autosomal dominant disorder characterized by multi-organ pathologies. Most TSC patients exhibit seizures, usually starting in early childhood. The neuropathological hallmarks of the disease - cortical tubers, containing cytopathological neuronal and glial cell types - appear to be the source of seizure initiation. However, the contribution of these aberrant cell populations to TSC-associated epilepsies is not fully understood. To gain further insight, investigators have attempted to generate animal models with TSC-like brain abnormalities. In the current study, we focused on the Eker rat, in which there is a spontaneous mutation of the TSC2 gene (TSC2+/-). We attempted to exacerbate TSC-like brain pathologies with a "second-hit" strategy - exposing young pups to ionizing irradiation of different intensities, and at different developmental timepoints (between E18 and P6). We found that the frequency of occurrence of dysmorphic neurons and giant astrocytes was strongly dependent on irradiation dose, and weakly dependent on timing of irradiation in Eker rats, but not in irradiated normal controls. The frequency of TSC-like pathology was progressive; there were many more abnormal cells at 3 months compared to 1 month post-irradiation. Measures of seizure propensity (flurothyl seizure latency) and brain excitability (paired-pulse and post-tetanic stimulation studies in vitro), however, showed no functional changes associated with the appearance of TSC-like cellular abnormalities in irradiated Eker rats.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17011168      PMCID: PMC1905148          DOI: 10.1016/j.eplepsyres.2006.08.003

Source DB:  PubMed          Journal:  Epilepsy Res        ISSN: 0920-1211            Impact factor:   3.045


  68 in total

1.  Synaptic responses of neurons in heterotopic gray matter in an animal model of cortical dysgenesis.

Authors:  B N Smith; F E Dudek; S N Roper
Journal:  Dev Neurosci       Date:  1999-11       Impact factor: 2.984

2.  Synaptically driven spikes and long-term potentiation in neocortical layer 2/3.

Authors:  E C Walcott; R B Langdon
Journal:  Neuroscience       Date:  2002       Impact factor: 3.590

3.  PRENATAL CHRONIC GAMMA IRRADIATION AND AUDIOGENIC SEIZURES IN RATS.

Authors:  J P COOKE; S O BROWN; G M KRISE
Journal:  Exp Neurol       Date:  1964-03       Impact factor: 5.330

4.  Tuberous sclerosis in a 20-week gestation fetus: immunohistochemical study.

Authors:  S H Park; S H Pepkowitz; C Kerfoot; M J De Rosa; V Poukens; R Wienecke; J E DeClue; H V Vinters
Journal:  Acta Neuropathol       Date:  1997-08       Impact factor: 17.088

5.  Electrophysiology of CA1 pyramidal neurons in an animal model of neuronal migration disorders: prenatal methylazoxymethanol treatment.

Authors:  S C Baraban; P A Schwartzkroin
Journal:  Epilepsy Res       Date:  1995-10       Impact factor: 3.045

6.  Differential radiosensitivity of stationary and migratory primitive cells in the brains of infant rats.

Authors:  J Altman; W J Anderson; K A Wright
Journal:  Exp Neurol       Date:  1968-09       Impact factor: 5.330

7.  mTOR cascade activation distinguishes tubers from focal cortical dysplasia.

Authors:  Marianna Baybis; Jia Yu; Allana Lee; Jeff A Golden; Howard Weiner; Guy McKhann; Eleonora Aronica; Peter B Crino
Journal:  Ann Neurol       Date:  2004-10       Impact factor: 10.422

8.  Tuberous sclerosis: relationships between topographic mapping of EEG, VEPs and MRI findings.

Authors:  S Seri; A Cerquiglini; R Cusmai; P Curatolo
Journal:  Neurophysiol Clin       Date:  1991-08       Impact factor: 3.734

9.  Surgical treatment of epilepsy in tuberous sclerosis: strategies and results in 18 patients.

Authors:  M M Guerreiro; F Andermann; E Andermann; A Palmini; P Hwang; H J Hoffman; H Otsubo; A Bastos; F Dubeau; G J Snipes; A Olivier; T Rasmussen
Journal:  Neurology       Date:  1998-11       Impact factor: 9.910

10.  Flurothyl seizure susceptibility in rats following prenatal methylazoxymethanol treatment.

Authors:  S C Baraban; P A Schwartzkroin
Journal:  Epilepsy Res       Date:  1996-04       Impact factor: 3.045

View more
  7 in total

Review 1.  Mechanisms of epileptogenesis in tuberous sclerosis complex and related malformations of cortical development with abnormal glioneuronal proliferation.

Authors:  Michael Wong
Journal:  Epilepsia       Date:  2007-08-28       Impact factor: 5.864

2.  The natural history and treatment of epilepsy in a murine model of tuberous sclerosis.

Authors:  Ebru Erbayat-Altay; Ling-Hui Zeng; Lin Xu; David H Gutmann; Michael Wong
Journal:  Epilepsia       Date:  2007-05-01       Impact factor: 5.864

3.  Zebrafish model of tuberous sclerosis complex reveals cell-autonomous and non-cell-autonomous functions of mutant tuberin.

Authors:  Seok-Hyung Kim; Christina K Speirs; Lilianna Solnica-Krezel; Kevin C Ess
Journal:  Dis Model Mech       Date:  2010-10-19       Impact factor: 5.758

4.  Dampened hippocampal oscillations and enhanced spindle activity in an asymptomatic model of developmental cortical malformations.

Authors:  Elena Cid; Daniel Gomez-Dominguez; David Martin-Lopez; Beatriz Gal; François Laurent; Jose M Ibarz; Fiona Francis; Liset Menendez de la Prida
Journal:  Front Syst Neurosci       Date:  2014-04-14

5.  mTOR inhibitor improves autistic-like behaviors related to Tsc2 haploinsufficiency but not following developmental status epilepticus.

Authors:  Tomas Petrasek; Iveta Vojtechova; Ondrej Klovrza; Klara Tuckova; Cestmir Vejmola; Jakub Rak; Anna Sulakova; Daniel Kaping; Nadine Bernhardt; Petrus J de Vries; Jakub Otahal; Robert Waltereit
Journal:  J Neurodev Disord       Date:  2021-04-17       Impact factor: 4.025

6.  Tuberous Sclerosis (tsc2+/-) Model Eker Rats Reveals Extensive Neuronal Loss with Microglial Invasion and Vascular Remodeling Related to Brain Neoplasia.

Authors:  Viera Kútna; Libor Uttl; Robert Waltereit; Zdenka Krištofiková; Daniel Kaping; Tomáš Petrásek; Cyril Hoschl; Saak V Ovsepian
Journal:  Neurotherapeutics       Date:  2020-01       Impact factor: 7.620

Review 7.  Revisiting Brain Tuberous Sclerosis Complex in Rat and Human: Shared Molecular and Cellular Pathology Leads to Distinct Neurophysiological and Behavioral Phenotypes.

Authors:  Viera Kútna; Valerie B O'Leary; Ehren Newman; Cyril Hoschl; Saak V Ovsepian
Journal:  Neurotherapeutics       Date:  2021-01-04       Impact factor: 7.620

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.